Adam Sharp
@asharpmedonc.bsky.social
Academic medical oncologist. Interested in biology, prostate cancer and drug development. Husband/Dad/Sport. Views my own and no specific advice/DMs.
Reposted by Adam Sharp
NEWS 📰: New drug combination could tackle advanced #ProstateCancer
40% of advanced prostate cancer patients could be treated with a combination of 2 drugs. The drugs are already in use or in trials to treat cancer.
Read more about the work published in
@natcomms.nature.com ⬇️
40% of advanced prostate cancer patients could be treated with a combination of 2 drugs. The drugs are already in use or in trials to treat cancer.
Read more about the work published in
@natcomms.nature.com ⬇️
New drug combination to tackle advanced prostate cancer
New drug combination to tackle advanced prostate cancer
www.icr.ac.uk
October 15, 2025 at 9:13 AM
NEWS 📰: New drug combination could tackle advanced #ProstateCancer
40% of advanced prostate cancer patients could be treated with a combination of 2 drugs. The drugs are already in use or in trials to treat cancer.
Read more about the work published in
@natcomms.nature.com ⬇️
40% of advanced prostate cancer patients could be treated with a combination of 2 drugs. The drugs are already in use or in trials to treat cancer.
Read more about the work published in
@natcomms.nature.com ⬇️
Reposted by Adam Sharp
🚨 Delighted to share our latest paper, from
@asharpmedonc.bsky.social team in collaboration with Johann de Bono’s team at @icr.ac.uk and international colleagues, published in Nature Communications @natureportfolio.nature.com
Read here: bit.ly/477pYt7
🧵1/4
@asharpmedonc.bsky.social team in collaboration with Johann de Bono’s team at @icr.ac.uk and international colleagues, published in Nature Communications @natureportfolio.nature.com
Read here: bit.ly/477pYt7
🧵1/4
October 15, 2025 at 1:48 PM
🚨 Delighted to share our latest paper, from
@asharpmedonc.bsky.social team in collaboration with Johann de Bono’s team at @icr.ac.uk and international colleagues, published in Nature Communications @natureportfolio.nature.com
Read here: bit.ly/477pYt7
🧵1/4
@asharpmedonc.bsky.social team in collaboration with Johann de Bono’s team at @icr.ac.uk and international colleagues, published in Nature Communications @natureportfolio.nature.com
Read here: bit.ly/477pYt7
🧵1/4
Reposted by Adam Sharp
Could targeting MCL1 be a new treatment approach for hormone therapy-resistant #ProstateCancer?
A study in @natcomms.nature.com by @juanjimenezvacas.bsky.social, @asharpmedonc.bsky.social and the @icr.ac.uk team explores precision therapy strategies.
Grab a ☕ and read: doi.org/10.1038/s414...
A study in @natcomms.nature.com by @juanjimenezvacas.bsky.social, @asharpmedonc.bsky.social and the @icr.ac.uk team explores precision therapy strategies.
Grab a ☕ and read: doi.org/10.1038/s414...
October 14, 2025 at 4:02 PM
Could targeting MCL1 be a new treatment approach for hormone therapy-resistant #ProstateCancer?
A study in @natcomms.nature.com by @juanjimenezvacas.bsky.social, @asharpmedonc.bsky.social and the @icr.ac.uk team explores precision therapy strategies.
Grab a ☕ and read: doi.org/10.1038/s414...
A study in @natcomms.nature.com by @juanjimenezvacas.bsky.social, @asharpmedonc.bsky.social and the @icr.ac.uk team explores precision therapy strategies.
Grab a ☕ and read: doi.org/10.1038/s414...
Waiting for the water to return. Still a 🏃 just not by 💦
March 9, 2025 at 9:59 AM
Waiting for the water to return. Still a 🏃 just not by 💦
Reposted by Adam Sharp
A great talk Adam, really enjoyed hearing about the breadth of your work!
March 3, 2025 at 6:38 PM
A great talk Adam, really enjoyed hearing about the breadth of your work!
Thanks for coming out today. A home game 🥰
March 3, 2025 at 6:30 PM
Thanks for coming out today. A home game 🥰
We keep pushing. Wishing you all some Friday happiness 🥰.
February 28, 2025 at 6:44 AM
We keep pushing. Wishing you all some Friday happiness 🥰.
Sleep seems to be optional currently! Big love to all 🥰
February 20, 2025 at 5:35 AM
Sleep seems to be optional currently! Big love to all 🥰
Thank you for the invite and the innovative format. Was great to chat with such an enthusiastic and engaged group. Super hospitality. Thank you for the awesome discussion 😊
@asharpmedonc.bsky.social gave an excellent discussion on #prostate cancer, highlighting unanswered biological questions and treatment challenges, during our Whiteboard Meeting.
February 19, 2025 at 11:01 PM
Thank you for the invite and the innovative format. Was great to chat with such an enthusiastic and engaged group. Super hospitality. Thank you for the awesome discussion 😊
So he has opted for our bed tonight with Mrs S. Double sleep divorce 😞
February 18, 2025 at 11:41 PM
So he has opted for our bed tonight with Mrs S. Double sleep divorce 😞
Timeline cleanse. Does this make me Batman 🥰
February 17, 2025 at 2:37 PM
Timeline cleanse. Does this make me Batman 🥰
The unit and sensitivity of measurement may change, but good is good and bad is bad, we may need more innovation to move from incremental to transformational.
February 16, 2025 at 9:20 PM
The unit and sensitivity of measurement may change, but good is good and bad is bad, we may need more innovation to move from incremental to transformational.
One upon a time it was punter and pige - having now met @profiand.bsky.social @craiggedye.bsky.social in person - I have new favourite 🇦🇺!
February 16, 2025 at 4:12 PM
One upon a time it was punter and pige - having now met @profiand.bsky.social @craiggedye.bsky.social in person - I have new favourite 🇦🇺!
We need to be mindful - we have little knowledge on how the androgen receptor works in prostate cancer. Remains a key area of research and for me the main target.
Beyond prostate cancer: Androgen receptor signaling plays a key role in multiple malignancies. Dotto & collegues explore AR’s context-dependent functions in cancer cells & the TME, and highlight AR-targeting cancer trials.
📖 👇
📖 👇
Androgen receptor signalling in non-prostatic malignancies: challenges and opportunities - Nature Reviews Cancer
go.nature.com
February 16, 2025 at 4:08 PM
We need to be mindful - we have little knowledge on how the androgen receptor works in prostate cancer. Remains a key area of research and for me the main target.
Thank you Seattle and San Fransisco for a lovely week. @fredhutch.bsky.social @ascocancer.bsky.social #GU
February 16, 2025 at 10:05 AM
Thank you Seattle and San Fransisco for a lovely week. @fredhutch.bsky.social @ascocancer.bsky.social #GU
Loved this 😊
Finally meeting @asharpmedonc.bsky.social in person #GU25
February 15, 2025 at 12:19 AM
Loved this 😊
Morning Manchester!
January 27, 2025 at 9:02 AM
Morning Manchester!
Reposted by Adam Sharp
Looking forward to #JING25 - annual meeting for early career researchers in experimental cancer medicine. Welcome to Manchester, everyone.
@cancerresearchuk.org @oncocook.bsky.social @mcrcnews.bsky.social @asharpmedonc.bsky.social @ukecrc.bsky.social
www.ecmcnetwork.org.uk/jing-tng
@cancerresearchuk.org @oncocook.bsky.social @mcrcnews.bsky.social @asharpmedonc.bsky.social @ukecrc.bsky.social
www.ecmcnetwork.org.uk/jing-tng
JING: Training the Next Generation event | ECMC
www.ecmcnetwork.org.uk
January 26, 2025 at 9:22 AM
Looking forward to #JING25 - annual meeting for early career researchers in experimental cancer medicine. Welcome to Manchester, everyone.
@cancerresearchuk.org @oncocook.bsky.social @mcrcnews.bsky.social @asharpmedonc.bsky.social @ukecrc.bsky.social
www.ecmcnetwork.org.uk/jing-tng
@cancerresearchuk.org @oncocook.bsky.social @mcrcnews.bsky.social @asharpmedonc.bsky.social @ukecrc.bsky.social
www.ecmcnetwork.org.uk/jing-tng
@annaminchom.bsky.social and I will be doing a very slow jog on Tuesday am at ECMC JING meeting. Meet in foyer around 7am. Plenty of time for it to be a social jog, shower and breakie before we begin day 2. Can’t wait (for the meeting)!
January 25, 2025 at 11:40 AM
@annaminchom.bsky.social and I will be doing a very slow jog on Tuesday am at ECMC JING meeting. Meet in foyer around 7am. Plenty of time for it to be a social jog, shower and breakie before we begin day 2. Can’t wait (for the meeting)!
Reposted by Adam Sharp
Huge thanks to you and your colleagues for all you do to improve outcomes for cancer patients and their families. Research is where hope starts!
January 24, 2025 at 7:00 PM
Huge thanks to you and your colleagues for all you do to improve outcomes for cancer patients and their families. Research is where hope starts!
Reposted by Adam Sharp
We’re on our way! Looking forward to hearing from your researchers @icrlondon.bsky.social and the hope for prostate cancer patients in the future
January 24, 2025 at 7:44 AM
We’re on our way! Looking forward to hearing from your researchers @icrlondon.bsky.social and the hope for prostate cancer patients in the future
Reposted by Adam Sharp
An inspirational day for @pjmcg.bsky.social and me @icrlondon.bsky.social with @asharpmedonc.bsky.social and his team of researchers. Thanks for all you’re doing to bring hope to men with #prostatecancer. @ethansgrumps.bsky.social - great to meet you at last. Thanks for all you do too! ❤️
Beyond grateful to @ethansgrumps.bsky.social @sueduncombe.bsky.social @pjmcg.bsky.social for the time spent with our fabulous team @icrlondon.bsky.social. Supporting them develop the ability to describe complex science to public/patients and asking tough questions on how we translate to the clinic.
January 24, 2025 at 5:31 PM
An inspirational day for @pjmcg.bsky.social and me @icrlondon.bsky.social with @asharpmedonc.bsky.social and his team of researchers. Thanks for all you’re doing to bring hope to men with #prostatecancer. @ethansgrumps.bsky.social - great to meet you at last. Thanks for all you do too! ❤️
Beyond grateful to @ethansgrumps.bsky.social @sueduncombe.bsky.social @pjmcg.bsky.social for the time spent with our fabulous team @icrlondon.bsky.social. Supporting them develop the ability to describe complex science to public/patients and asking tough questions on how we translate to the clinic.
January 24, 2025 at 4:58 PM
Beyond grateful to @ethansgrumps.bsky.social @sueduncombe.bsky.social @pjmcg.bsky.social for the time spent with our fabulous team @icrlondon.bsky.social. Supporting them develop the ability to describe complex science to public/patients and asking tough questions on how we translate to the clinic.